
Court rules against generics companies in infringement suit concerning diabetes
The Himachal Pradesh High Court recently issued ad-interim
injunctions to a patentee, Boehringer Ingelheim (BI), against five Indian
generic companies (the defendants).
BI filed separate infringement suits against the companies and sought interim injunctions to restrain them from violating its patent rights during the...